Inhibitors of hepatitis C virus NS3 protease
US6653295B2 · kind B2 · utility
40Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 12, 2001 |
| Grant date | Nov 25, 2003 |
| Priority date | — |
| Expiry date | Jan 3, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K5/06191
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates generally to a novel class of pyrimidinones of Formula (I): that are useful as serine protease inhibitors, and more particularly as Hepatitis C virus NS3 protease inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.